Author: LaQuinta Jernigan

mdtalk Episode 2: Raising Awareness of Clinical Trials in Diverse Communities

Posted

In our first episode, we discussed why increasing diversity in clinical trials matters, and the impact a lack of diversity has on equity in health care. Our second episode focuses on the importance of actively raising awareness of clinical research in minority communities, and how we can do that effectively.

Why Diversity In Clinical Trials Is Vital

Posted

My passion for diversity in clinical trials comes from many different places. For starters, I’m from a diverse community. It’s important to me that I, my family, and my children are well-represented in clinical research so we can have the best treatments and therapies available to us, should we need them.

mdTalk Episode 1: Why Diversity in Clinical Trials Matters with Karen Correa, PhD

Posted

LaQuinta Jernigan, Executive Vice President for the Americas at mdgroup, speaks to Karen Correa, PhD. Karen is the current VP, Head of Global Clinical Operations at Takeda, and has almost 30 years of experience in clinical research with a specialist focus on diversity and inclusion. Karen not only brings huge passion to her work but also uses her personal experience and expert knowledge to mentor young women and girls pursuing careers in STEM.

Meet our Executive Vice President for the Americas, LaQuinta Jernigan

Posted

Passionate about putting the patient at the heart of everything we do, LaQuinta shares what she has learnt through the challenges of the pandemic, what she thinks sets us apart from our competitors, and what exciting developments we can expect to see for the company in 2021.

The Importance of the Patient Voice to the 21st Century Cures Act

Posted

The 21st Century Cures Act was nothing short of revolutionary. Signed into U.S. law on December 13th 2016, it is designed to support the acceleration of medical product development and bring new innovations and advances to patients who need them (FDA.com).

Why We Need To Improve Diversity Amongst Clinical Trial Participants

Posted

We explore the issues faced when people of white, European descent are over-represented in clinical trials, the benefits of a diverse patient population on trial outcomes, and how researchers can engage with minority populations to increase diversity among participants to improve overall drug development.